Ascrinvacumab (PF-03446962) is a monoclonal antibody designed for the treatment of cancer.
Statement On A Nonproprietary Name Adopted By The USAN Council - Ascrinvacumab
''American Medical Association
The American Medical Association (AMA) is a professional association and lobbying group of physicians and medical students. Founded in 1847, it is headquartered in Chicago, Illinois. Membership was approximately 240,000 in 2016.
The AMA's sta ...
''.
This drug was developed by Pfizer
Pfizer Inc. ( ) is an American multinational pharmaceutical and biotechnology corporation headquartered on 42nd Street in Manhattan, New York City. The company was established in 1849 in New York by two German entrepreneurs, Charles Pfizer ...
Inc.
References
{{TGFβ receptor superfamily modulators
Monoclonal antibodies
Experimental cancer drugs